Medicines Formulary

Reports

Status	Drug name	NICE TAs	Comments
	Metformin tablets
	Methylprednisolone acetate
	Methylprednisolone acetate injection
	Methylprednisolone/lidocaine injection
	Metoclopramide injections		Not recommended for patients aged 20 years and below due to risk of dystonic reactions. MHRA guidance - metroclopramide: risk of neurological adverse effects
	Metoclopramide suspension		Not recommended for patients aged 20 years and below due to risk of dystonic reactions. MHRA guidance - metroclopramide: risk of neurological adverse effects
	Metoclopramide tablets		Not recommended for patients aged 20 years and below due to risk of dystonic reactions. MHRA guidance - metroclopramide: risk of neurological adverse effects
	Metoclopramide tablets
	Metoprolol M/R tablets
	Metoprolol tablets

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.